These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12689940)

  • 1. Synergy between tumor immunotherapy and antiangiogenic therapy.
    Nair S; Boczkowski D; Moeller B; Dewhirst M; Vieweg J; Gilboa E
    Blood; 2003 Aug; 102(3):964-71. PubMed ID: 12689940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
    Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
    Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
    Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
    Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
    Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of mRNA for vascular endothelial growth factor (VEGF), angiopoietins and their receptors during the peri-implantation period and early pregnancy in marmosets (Callithrix jacchus).
    Rowe AJ; Wulff C; Fraser HM
    Reproduction; 2003 Aug; 126(2):227-38. PubMed ID: 12887279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.
    Niederman TM; Ghogawala Z; Carter BS; Tompkins HS; Russell MM; Mulligan RC
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7009-14. PubMed ID: 11997459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
    Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
    Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
    Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.
    Wang Y; Zhang J; Wu Y; Ding ZY; Luo XM; Liu J; Zhong WN; Deng GH; Xia XY; Deng YT; Wei YQ; Jiang Y
    Sci Rep; 2015 Jun; 5():11275. PubMed ID: 26085010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target gene.
    Jin N; Chen W; Blazar BR; Ramakrishnan S; Vallera DA
    Hum Gene Ther; 2002 Mar; 13(4):497-508. PubMed ID: 11874628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice.
    Cuadros C; Dominguez AL; Frost GI; Borgstrom P; Lustgarten J
    Cancer Res; 2003 Sep; 63(18):5895-901. PubMed ID: 14522915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
    Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
    Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.
    Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
    Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.